FADS2 and breast carcinoma: While individual SCD1 and FADS2 inhibition yielded significant decreases in LCL growth, their collective role as desaturase enzymes begged the question of whether they might be acting in a complementary manner to create diverse desaturated lipid species that favor growth, as demonstrated in breast cancer cells [31].